INFUSE BONE GRAFT
Report
- Report Number
- 1030489-2012-01961
- Event Type
- Injury
- Date Received
- October 24, 2012
- Report Date
- September 24, 2012
- Manufacturer
- MEDTRONIC SOFAMOR DANEK USA, INC
- Product Code
- NEK
- PMA / PMN Number
- P000058
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- ATTORNEY
Narratives
(B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES. ALSO SEE MEDWATCH REPORT NUMBERS 1030489-2012-01865 AND 1030489-2012-01960.
IT WAS REPORTED THAT THE PATIENT UNDERWENT A SURGICAL PROCEDURE FOR REMOVAL OF THE INTERBODY CAGE AT L3-4 DUE TO "REPEATED RETROPULSION. HE HAD DEVELOPED RADICULAR SYMPTOMS AGAIN AND IMAGING CONFIRMED THE CAGE HAD AGAIN SUBSIDED." THE CAGE WAS REMOVED. "A FULL INSPECTION OF THE NERVOUS STRUCTURES WAS PERFORMED. NO DAMAGE OR CSF EGRESS WAS NOTED." "SOLID ARTHRODESIS WAS NOTED ANTERIORLY AND LATERALLY." THE SPACE OCCUPIED BY THE CAGE WAS FILLED WITH RHBMP-2/ACS SPONGES FOR ARTHRODESIS. GEL FOAM AND SURGICELL WERE PLACED AS A BARRIER VENTRAL TO THE SAC AND DORSAL TO THE SPONGES. ALLEGEDLY, POST-OPERATIVELY, THE PATIENT HAS DEVELOPED "EXCRUCIATING PAIN, SEVERE MUSCLE SPASMS, CAGE MIGRATION (TWICE), DURA SAC PUNCTURE, BONE GROWTH, NUMBNESS, BLADDER PROBLEMS, SPINAL FLUID LEAKS, CEREBRAL FLUID LEAKS, HEADACHES, LEFT SIDE PARALYSIS, SLAPFOOT, SLIGHT MOVEMENT AT BIG TOE."
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | INFUSE BONE GRAFT | FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET | NEK | MEDTRONIC SOFAMOR DANEK USA, INC | NA | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention | GEL FOAM AND SURGICELL |